Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Karlsen, Karine Flem"'
Autor:
Benjakul, Sopisa, Anthi, Aina Karen, Kolderup, Heidi Anette, Vaysburd, Marina, Lode, Heidrun Elisabeth, Mallery, D, Fossum, Even, Vikse, Elisabeth Lea, Albecka, Anna, Ianevski, Aleksandr, Kaynov, Denis, Karlsen, Karine Flem, Sakya, Siri Aastedatter, Nyquist-Andersen, Mari, gjølberg, torleif, Moe, Morten Carsten, Bjørås, Magnar, Sandlie, Inger, James, Leo C., Andersen, Jan Terje
Externí odkaz:
https://hdl.handle.net/11250/3121035
Autor:
Karlsen, Karine Flem, McFadden, Erin, Omar, Nasrin, Haugen, Mads Haugland, Øy, Geir Frode, Ryder, Truls, Gullestad, Hans Petter, Hermann, Robert, Mælandsmo, Gunhild Mari, Flørenes, Vivi Ann
Publikováno v:
Karlsen, Karine Flem McFadden, Erin Omar, Nasrin Haugen, Mads Haugland Øy, Geir Frode Ryder, Truls Gullestad, Hans Petter Hermann, Robert Mælandsmo, Gunhild Mari Flørenes, Vivi Ann . Targeting AXL and the DNA damage response pathway as a novel therapeutic strategy in melanoma. Molecular Cancer Therapeutics. 2019
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
Autor:
Karlsen, Karine Flem, McFadden, Erin, Omar, Nasrin, Haugen, Mads Haugland, Øy, Geir Frode, Ryder, Truls, Gullestad, Hans Petter, Hermann, Robert, Mælandsmo, Gunhild Mari, Flørenes, Vivi Ann
Publikováno v:
Karlsen, McFadden E, Omar, Haugen MH, Øy GF, Ryder T, Gullestad HP, Hermann R, Mælandsmo GM, Flørenes VA. Targeting AXL and the DNA damage response pathway as a novel therapeutic strategy in melanoma. Molecular Cancer Therapeutics. 2019
Externí odkaz:
https://hdl.handle.net/10037/17338
Publikováno v:
Karlsen, Karine Flem Fodstad, Øystein Tan, Ming Nunes-Xavier, Caroline Elisabeth . B7-H3 in Cancer ? Beyond Immune Regulation. Trends in Cancer. 2018
Trends in Cancer
Trends in Cancer
Autor:
Karlsen, Karine Flem, Tekle, Christina, Andersson, Yvonne, Flatmark, Kjersti, Fodstad, Øystein, Nunes-Xavier, Caroline Elisabeth
Publikováno v:
Karlsen, Karine Flem Tekle, Christina Andersson, Yvonne Flatmark, Kjersti Fodstad, Øystein Nunes-Xavier, Caroline Elisabeth . Immunoregulatory protein B7-H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cells.. Pigment Cell & Melanoma Research. 2017, 30(5), 467-476
Pigment Cell & Melanoma Research
Pigment Cell & Melanoma Research
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Benjakul S; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo 0372, Norway.; Department of Immunology, Oslo University Hospital Rikshospitalet, Oslo 0372, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo 0372, Norway., Anthi AK; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo 0372, Norway.; Department of Immunology, Oslo University Hospital Rikshospitalet, Oslo 0372, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo 0372, Norway., Kolderup A; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo 0372, Norway.; Department of Immunology, Oslo University Hospital Rikshospitalet, Oslo 0372, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo 0372, Norway., Vaysburd M; Protein and Nucleic Acid Chemistry Division, Medical Research Council, Laboratory of Molecular Biology, Cambridge CB2 0QH, UK., Lode HE; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo 0372, Norway.; Department of Immunology, Oslo University Hospital Rikshospitalet, Oslo 0372, Norway.; Department of Ophthalmology, Oslo University Hospital and University of Oslo, Oslo 0450, Norway., Mallery D; Protein and Nucleic Acid Chemistry Division, Medical Research Council, Laboratory of Molecular Biology, Cambridge CB2 0QH, UK., Fossum E; Department of Virology, Norwegian Institute of Public Health, Oslo 0213, Norway., Vikse EL; Department of Virology, Norwegian Institute of Public Health, Oslo 0213, Norway., Albecka A; Protein and Nucleic Acid Chemistry Division, Medical Research Council, Laboratory of Molecular Biology, Cambridge CB2 0QH, UK., Ianevski A; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway., Kainov D; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway.; Institute of Technology, University of Tartu, Tartu 50411, Estonia.; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki 00290, Finland., Karlsen KF; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo 0372, Norway.; Department of Immunology, Oslo University Hospital Rikshospitalet, Oslo 0372, Norway., Sakya SA; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo 0372, Norway.; Department of Immunology, Oslo University Hospital Rikshospitalet, Oslo 0372, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo 0372, Norway., Nyquist-Andersen M; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo 0372, Norway.; Department of Immunology, Oslo University Hospital Rikshospitalet, Oslo 0372, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo 0372, Norway., Gjølberg TT; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo 0372, Norway.; Department of Immunology, Oslo University Hospital Rikshospitalet, Oslo 0372, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo 0372, Norway.; Department of Ophthalmology, Oslo University Hospital and University of Oslo, Oslo 0450, Norway., Moe MC; Department of Ophthalmology, Oslo University Hospital and University of Oslo, Oslo 0450, Norway., Bjørås M; Department of Virology, Norwegian Institute of Public Health, Oslo 0213, Norway., Sandlie I; Department of Biosciences, University of Oslo, Oslo 0371, Norway., James LC; Protein and Nucleic Acid Chemistry Division, Medical Research Council, Laboratory of Molecular Biology, Cambridge CB2 0QH, UK., Andersen JT; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo 0372, Norway.; Department of Immunology, Oslo University Hospital Rikshospitalet, Oslo 0372, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo 0372, Norway.
Publikováno v:
PNAS nexus [PNAS Nexus] 2023 Nov 28; Vol. 2 (12), pp. pgad403. Date of Electronic Publication: 2023 Nov 28 (Print Publication: 2023).